Affiliation:
1. National Research Oncology Center
2. RUDN University
Abstract
The study objective is to evaluate the effectiveness of using superselective embolization of the renal arterial bed prior to organ-preserving laparoscopic kidney tumor resection.Materials and methods. At the Center for Urology, Kidney Transplantation and Nephrology of the National Research Oncology Center (Nur-Sultan, Kazakhstan) between 2015 and 2019 laparoscopic kidney tumor resection was performed in 45 patients; in 9 patients with stage T1 kidney tumors, superselective embolization was also performed. Mean age of the patients was 54 years, mean tumor diameter was 2.8 cm. Localization near the kidney pole and presence of an artery isolatedly supplying the tumor were the main indications for superselective embolization of the feeding artery prior to kidney resection.Results. Mean blood loss was 280 ml. Complications characteristic of post-embolization period (pain, fever, arterial hypertension), as well as loss of function of the organ, were absent 3, 6 and 12 months after the procedure per laboratory and radiological examinations.Conclusion. Superselective embolization of the tumor feeding artery is an effective method allowing to minimize warm ischemia of the renal parenchyma and perform kidney resection with minimal blood loss.The authors declare no conflict of interest.All patients gave written informed consent to participate in the study and to the publication of their data.
Publisher
Publishing House ABV Press
Subject
Urology,Reproductive Medicine,Surgery
Reference14 articles.
1. Haber G.P., Gill I.S. Laparoscopic partial nephrectomy: contemporary technique and outcomes. Eur Urol 2006;49(4):660–5. DOI: 10.1016/j.eururo.2006.02.001.
2. Wille A.H., Tüllmann M., Roigas J. et al. Laparoscopic partial nephrectomy in renal cell cancer – results and reproducibility by different surgeons in a high volume laparoscopic center. Eur Urol 2006;49(2):337–42. DOI: 10.1016/j.eururo.2005.11.016.
3. Nguyen M.M., Gill I.S., Ellison L.M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 2006;176(6 Pt 1):2397–400. DOI: 10.1016/j.juro.2006.07.144.
4. Chow W.H., Devesa S.S., Warren J.L., Freumeni J.F. Jr. Rising incidence of renal cell carcer in the United States. JAMA 1999;281(17):1628–31. DOI: 10.1001/jama.281.17.1628.
5. Alyaev Yu.G., Shpot' E.V. Rak pochki. Proshloe, nastoyashchee i budushchee. Farmateka 2010;18–19:14–9. [Alyaev Yu.G., Shpot E.V. Renal cell carcinoma. Past, present and future. Farmateka = Pharmateca 2010; 18–19:14–9. (In Russ.)].